Blog
FDA Clears CardioComm Solutions’ GUAVA II ECG Viewer with ECG Acquisition, Analysis, Interpretation, and Reporting Capabilities as a Class II Medical Device
GUAVA II offers regulatory credibility and efficiency to ECG reading services for physicians and hospitals TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX...
CardioComm Solutions Completes Technology Pilot in the Long-Term Patient Care Market with the HeartCheck™ ECG Monitor and SMART Monitoring ECG Service Technologies
Arrhythmia Surveillance Utilized HeartCheck™ Device and SMART Monitoring ECG Service Technologies TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX...
CardioComm Solutions Executes Distribution and Co-Marketing Agreement to Promote HeartCheck™ PEN Sales and SMART Monitoring Services
SMART Monitoring Integration of Reka ECG monitoring device to provide access to new US-based and Global ECG Service Markets TORONTO, ONTARIO - CardioComm...
CardioComm Solutions Updates GEMS™ Arrhythmia Management Software License Agreement
Ammendment to reflect the new release of GEMS™ WIN as a Windows 7 compatible ECG management software upgrade TORONTO, ONTARIO - CardioComm Solutions,...
CardioComm Solutions Issues Stock Options
TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm Solutions" or the "Company")today announced that an aggregate of 567,460...
CARDIOCOMM SOLUTIONS APPOINTS INDUSTRY VETERAN AS VP SALES AND MARKETING TO BUILD U.S. BASED PATIENT MONITORING SOFTWARE AND ECG SERVICES BUSINESS
Former Executive of ScottCare, CardioNet and Lifewatch Corporation Set to Drive Sales of GEMS? and Mobile Patient Monitoring Solutions into the U.S. Market...
CardioComm Solutions Announces Equity Financing
Funding will be used as bridge financing to complete Q1 2014 objectives. TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm...
CardioComm Solutions to Offer Free SMART Monitoring ECG Readings to HeartCheck™ Device Owners through GEMS Home in the United States
Free cardiac arrhythmia surveillance available at no cost to those with a physician prescription. Toronto, Canada – CardioComm Solutions, Inc....
CardioComm Solutions’ HeartCheck™ Technologies to be used in Canadian Parkinson’s Research Study.
Second CIHR and industry sponsored study to use HeartCheck and SMART Monitoring Technologies. Toronto, Canada – CardioComm Solutions, Inc. (TSX-V:EKG)...
CardioComm Solutions Issues Stock Options
TORONTO, ONTARIO – December 4, 2013. CardioComm Solutions, Inc. (“CardioComm Solutions” or the “Company”) (TSX VENTURE:EKG), a...
CARDIOCOMM SOLUTIONS COMPLETES MOBILE CARDIAC TELEMETRY SOFTWARE RELEASE FOR RAYTEL CARDIAC SERVICES
Raytel Cardiac Services will be the first to launch into the American MCT monitoring market using the CardioComm Solutions Wireless Arrhythmia Services...
CardioComm Solutions’ GEMS Home & SMART Monitoring Technologies Expanded To Support Prescription, HeartCheck™ Handheld ECG Devices
Rapid physician ECG interpretation services now available to patients, allied health care workers and physician groups. TORONTO, ONTARIO - CardioComm...
CardioComm Solutions Announces Shares for Services Transactions
TORONTO, ONTARIO – October 31, 2013, CardioComm Solutions, Inc. (“CardioComm Solutions” or the “Company”) (TSX VENTURE:EKG), a...
CardioComm Solutions Promotes HeartCheck™ PEN Consumer Awareness and Sales at the Toronto ZoomerShow
ZoomerShow Participation Caps Off a Busy Week of Marketing Initiatives to Build Mindshare for the HeartCheck™ PEN Handheld ECG Device TORONTO, ONTARIO -...
Remedy’sRx Pharmacy Banner Joins the CardioComm Solutions’ HeartCheck™ “Take Control” CBC Television Commercial Campaign
Interest grows as select pharmacies carry the HeartCheck™ PEN for sale in Ontario TORONTO, ONTARIO – CardioComm Solutions, Inc. (“CardioComm...
CardioComm Solutions’ HeartCheckTM ECG Screening Technologies Superior to Pulse Check for Atrial Fibrillation Screening and Detection
TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) confirms results from the...
CardioComm Solutions Announces Issuance of Shares and Stock Options
Toronto, Canada – CardioComm Solutions, Inc. ("CardioComm Solutions" or the "Company") (TSX VENTURE:EKG), a global medical provider of ECG acquisition...
CardioComm Solutions’ HeartCheck™ Technologies to be used in Canadian Clinical Arrhythmia Risk Screening and Stoke Prevention Trial.
CIHR and industry sponsored study to use HeartCheck™ PEN and ECG monitors to screen 8,000 people through in-pharmacy and primary care physician offices...
CardioComm Solutions Starts OTC HeartCheck™ PEN Pharmacy Sales, Supported by Launch of New HeartCheck™ “Take Control” Television Commercial Campaign
Select Total Health Pharmacies in Ontario to carry the HeartCheck™ PEN in association with the “Take Control” commercial airing on the CBC...
CardioComm Solutions Talks With The Wall Street Analysts
CEO Interview reviews opportunities in both the consumer and medical ECG services market TORONTO, ONTARIO – CardioComm Solutions, Inc. (CardioComm...
